Aeglea BioTherapeutics, Inc.
NASDAQ:AGLE
12.01 (USD) • At close November 27, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -83.815 | -65.801 | -80.893 | -78.254 | -44.348 | -27.236 | -21.698 | -11.295 | -10.347 |
| Depreciation & Amortization
| 1.567 | 1.576 | 0.996 | 0.418 | 0.293 | 0.249 | 0.132 | 0.089 | 0.019 |
| Deferred Income Tax
| 0 | 0.204 | -0.213 | -0.314 | 0.314 | 0.084 | -0.045 | 0.004 | 1.444 |
| Stock Based Compensation
| 7.111 | 8.038 | 6.256 | 4.876 | 4.28 | 2.492 | 1.221 | 0.767 | 0.147 |
| Change In Working Capital
| -5.503 | 1.833 | -2.54 | 7.104 | 7.201 | -0.198 | 1.45 | -1.34 | 0.026 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 3.078 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 3.904 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -2.641 | 1.065 | -0.544 | 2.583 | 0.239 | 0.164 | -0.008 | -0.169 | 0.102 |
| Other Working Capital
| -2.862 | 0.768 | -1.996 | 4.521 | -0.02 | -0.362 | 1.458 | -1.171 | -0.076 |
| Other Non Cash Items
| 0.496 | 0.434 | 0.619 | 0.478 | 0.067 | 0.078 | 0.055 | 0.797 | 2.82 |
| Operating Cash Flow
| -80.144 | -53.716 | -75.775 | -65.692 | -32.193 | -24.615 | -18.84 | -10.982 | -7.335 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -0.038 | -0.573 | -4.28 | -1.492 | -0.422 | -0.619 | -0.212 | -0.208 | -0.181 |
| Acquisitions Net
| 0.428 | -0.344 | -0.286 | 0.504 | 0.907 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -39.5 | -133.079 | -129 | -91.926 | -62.179 | -64.115 | -20.39 | -3.766 | 0 |
| Sales Maturities Of Investments
| 96.546 | 111.033 | 125.676 | 91.679 | 47.37 | 42.205 | 8.446 | 0 | 0 |
| Other Investing Activites
| -0.428 | 0.344 | 0.286 | -0.504 | -0.907 | 0 | 0.08 | -0.04 | -0.04 |
| Investing Cash Flow
| 57.008 | -22.619 | -7.604 | -1.739 | -15.231 | -22.529 | -12.076 | -4.014 | -0.221 |
| Financing Activities: | |||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 42.874 | 0 | 153.716 | 64.298 | 54.048 | 11.38 | 49.294 | 43.702 | 5.575 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 42.678 | 1.393 | 154.512 | 65.723 | 57.068 | 12.213 | 49.37 | 41.674 | 5.575 |
| Financing Cash Flow
| 42.678 | 1.393 | 154.512 | 65.723 | 57.068 | 12.213 | 49.37 | 41.674 | 5.575 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| -0.106 | -0.015 | 0.051 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 19.436 | -74.957 | 71.184 | -1.708 | 9.644 | -34.931 | 18.454 | 26.678 | -1.981 |
| Cash At End Of Period
| 36.416 | 16.98 | 91.937 | 20.753 | 22.461 | 12.817 | 47.748 | 29.294 | 2.616 |